Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. APGE.NASDAQ

Apogee Therapeutics Inc. Common Stock (APGE NASDAQ) stock market data APIs

$50 0.05(0.1%) as of July 26, 2024
Price chart is built with Anychart

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts.

Apogee Therapeutics Inc. Common Stock Financial Data Overview

49.95
50
-
50.88
48.88
14.19-72.29
2 816 M
42 881 K
0
-0.64
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'APGE',
Type: 'Common Stock',
Name: 'Apogee Therapeutics Inc. Common Stock',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG01H51WYQ5',
ISIN: NULL,
CUSIP: NULL,
CIK: '1974640',
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: '2023-07-14',
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Apogee Therapeutics Inc. Common Stock Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA 0
  • Earnings Per Share -1.84
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Apogee Therapeutics Inc. Common Stock Earnings via APIs

  • Latest Release 2024-05-29
  • EPS/Forecast -0.61

Get Apogee Therapeutics Inc. Common Stock End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Apogee Therapeutics Inc. Common Stock latest news via APIs

NewAmsterdam Pharma Announces Appointments of Mark C. McKenna and Wouter Joustra to its Board of Directors

NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage...

Insider Sale: Carl Dambkowski Sells Shares of Apogee Therapeutics Inc (APGE)

On July 3, 2024, Carl Dambkowski, the Chief Medical Officer of Apogee Therapeutics Inc (NASDAQ:APGE), sold 5,995 shares of the company. The transaction was filed on the same day with the SEC. Followin...
Do you have any questions?
support@eodhistoricaldata.com